These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36647601)

  • 1. Influence of dosing pattern of antipsychotics on treatment outcome of delirium in patients with advanced cancer.
    Abe A; Fujisawa D; Miyajima K; Takeuchi E; Takeuchi M; Mimura M; Imai K; Uemura K; Watanabe H; Matsuo N; Matsuda Y; Maeda I; Ogawa A; Yoshiuchi K; Iwase S
    Jpn J Clin Oncol; 2023 Mar; 53(4):321-326. PubMed ID: 36647601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and effectiveness of antipsychotic medication for delirium in patients with advanced cancer: A large-scale multicenter prospective observational study in real-world palliative care settings.
    Maeda I; Ogawa A; Yoshiuchi K; Akechi T; Morita T; Oyamada S; Yamaguchi T; Imai K; Sakashita A; Matsumoto Y; Uemura K; Nakahara R; Iwase S;
    Gen Hosp Psychiatry; 2020; 67():35-41. PubMed ID: 32950826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of antipsychotics for managing agitated delirium in patients with advanced cancer: a secondary analysis of a multicenter prospective observational study in Japan (Phase-R).
    Kurisu K; Inada S; Maeda I; Nobata H; Ogawa A; Iwase S; Uchida M; Akechi T; Amano K; Nakajima N; Morita T; Sumitani M; Yoshiuchi K
    Support Care Cancer; 2024 Feb; 32(3):147. PubMed ID: 38326487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Antipsychotic Dose With Survival of Advanced Cancer Patients With Delirium.
    Yokomichi N; Maeda I; Morita T; Yoshiuchi K; Ogawa A; Hisanaga T; Sakashita A; Nakahara R; Kaneishi K; Iwase S
    J Pain Symptom Manage; 2022 Jul; 64(1):28-36. PubMed ID: 35339614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-related problems of antipsychotics in treating delirium among elderly patients: A real-world observational study.
    Jenraumjit R; Somboon J; Chainan S; Chuenchom P; Wongpakaran N; Wongpakaran T
    J Clin Pharm Ther; 2021 Oct; 46(5):1274-1280. PubMed ID: 33768628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotics for treatment of delirium in hospitalised non-ICU patients.
    Burry L; Mehta S; Perreault MM; Luxenberg JS; Siddiqi N; Hutton B; Fergusson DA; Bell C; Rose L
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD005594. PubMed ID: 29920656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Effectiveness of Perospirone in Comparison to Risperidone for Treatment of Delirium in Patients with Advanced Cancer: A Multicenter Prospective Observational Study in Real-World Psycho-Oncology Settings.
    Inoue S; Maeda I; Ogawa A; Yoshiuchi K; Terada S; Yamada N
    Acta Med Okayama; 2022 Apr; 76(2):195-202. PubMed ID: 35503448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current practice of pharmacological treatment for hyperactive delirium in terminally ill cancer patients: results of a nationwide survey of Japanese palliative care physicians and liaison psychiatrists.
    Matsuda Y; Morita T; Oya K; Tagami K; Naito AS; Kashiwagi H; Otani H
    Jpn J Clin Oncol; 2022 Aug; 52(8):905-910. PubMed ID: 35595535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotics for delirium.
    Lonergan E; Britton AM; Luxenberg J; Wyller T
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005594. PubMed ID: 17443602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotics for delirium in the general hospital setting in consecutive 2453 inpatients: a prospective observational study.
    Hatta K; Kishi Y; Wada K; Odawara T; Takeuchi T; Shiganami T; Tsuchida K; Oshima Y; Uchimura N; Akaho R; Watanabe A; Taira T; Nishimura K; Hashimoto N; Usui C; Nakamura H
    Int J Geriatr Psychiatry; 2014 Mar; 29(3):253-62. PubMed ID: 23801358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Associated with the Effectiveness of Intravenous Administration of Chlorpromazine for Delirium in Patients with Terminal Cancer.
    Hasuo H; Kanbara K; Fujii R; Uchitani K; Sakuma H; Fukunaga M
    J Palliat Med; 2018 Sep; 21(9):1257-1264. PubMed ID: 29757064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial.
    Agar MR; Lawlor PG; Quinn S; Draper B; Caplan GA; Rowett D; Sanderson C; Hardy J; Le B; Eckermann S; McCaffrey N; Devilee L; Fazekas B; Hill M; Currow DC
    JAMA Intern Med; 2017 Jan; 177(1):34-42. PubMed ID: 27918778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapy for delirium in terminally ill adults.
    Finucane AM; Jones L; Leurent B; Sampson EL; Stone P; Tookman A; Candy B
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004770. PubMed ID: 31960954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Pharmacotherapy Does Not Improve Severity of Hypoactive Delirium in Patients with Advanced Cancer: Pharmacological Audit Study of Safety and Efficacy in Real World (Phase-R).
    Okuyama T; Yoshiuchi K; Ogawa A; Iwase S; Yokomichi N; Sakashita A; Tagami K; Uemura K; Nakahara R; Akechi T;
    Oncologist; 2019 Jul; 24(7):e574-e582. PubMed ID: 30610009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial.
    Girard TD; Pandharipande PP; Carson SS; Schmidt GA; Wright PE; Canonico AE; Pun BT; Thompson JL; Shintani AK; Meltzer HY; Bernard GR; Dittus RS; Ely EW;
    Crit Care Med; 2010 Feb; 38(2):428-37. PubMed ID: 20095068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Antipsychotics and Non-Pharmacotherapy for the Management of Delirium in People Receiving Palliative Care.
    Lee KY; Tan ECK; Hanrahan JR; Chircop C; Michael F; Ong JA
    J Pain Palliat Care Pharmacother; 2020 Dec; 34(4):225-236. PubMed ID: 32730108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperglycemia due to atypical antipsychotics in cancer patients with delirium].
    Suzuki S; Ichida Y; Fujisawa D; Ogawa A; Uchitomi Y; Endo K; Izumi K
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1523-6. PubMed ID: 23064064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversibility of delirium in Ill-hospitalized cancer patients: Does underlying etiology matter?
    Matsuda Y; Maeda I; Morita T; Yamauchi T; Sakashita A; Watanabe H; Kaneishi K; Amano K; Iwase S; Ogawa A; Yoshiuchi K;
    Cancer Med; 2020 Jan; 9(1):19-26. PubMed ID: 31696671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are common delirium assessment tools appropriate for evaluating delirium at the end of life in cancer patients?
    Uchida M; Morita T; Akechi T; Yokomichi N; Sakashita A; Hisanaga T; Matsui T; Ogawa A; Yoshiuchi K; Iwase S;
    Psychooncology; 2020 Nov; 29(11):1842-1849. PubMed ID: 32735046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.